These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32082310)

  • 1. Complement Activation Is Associated With Mortality in Patients With Necrotizing Soft-Tissue Infections-A Prospective Observational Study.
    Kristensen MK; Hansen MB; Madsen MB; Hansen CB; Pilely K; Hyldegaard O; Garred P
    Front Immunol; 2020; 11():17. PubMed ID: 32082310
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers of Necrotising Soft Tissue Infections Aspects of the Innate Immune Response.
    Hansen MB
    Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in the Complement Activation Product C4d and the Terminal Complement Complex sC5b-9 Is Associated with Disease Severity and a Fatal Outcome in Necrotizing Soft-Tissue Infection.
    Hedetoft M; Madsen MB; Hansen CB; Hyldegaard O; Garred P
    J Innate Immun; 2022; 14(4):355-365. PubMed ID: 34903692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study.
    Hua C; Sbidian E; Hemery F; Decousser JW; Bosc R; Amathieu R; Rahmouni A; Wolkenstein P; Valeyrie-Allanore L; Brun-Buisson C; de Prost N; Chosidow O
    J Am Acad Dermatol; 2015 Dec; 73(6):1006-12.e8. PubMed ID: 26412163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.
    Hansen MB; Rasmussen LS; Garred P; Bidstrup D; Madsen MB; Hyldegaard O
    Crit Care; 2016 Feb; 20():40. PubMed ID: 26880104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of mortality, limb loss, and discharge disposition at admission among patients with necrotizing skin and soft tissue infections.
    Horn DL; Shen J; Roberts E; Wang TN; Li KS; O'Keefe GE; Cuschieri J; Bulger EM; Robinson BRH
    J Trauma Acute Care Surg; 2020 Jul; 89(1):186-191. PubMed ID: 32102045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of organ dysfunction as a predictor of long-term survival in necrotizing soft tissue infections: Analysis of the AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections trial and a retrospective claims database-linked chart study.
    Brakenridge SC; Wilfret DA; Maislin G; Andrade KE; Walker V; May AK; Dankner WM; Bulger EM
    J Trauma Acute Care Surg; 2021 Aug; 91(2):384-392. PubMed ID: 33797490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: a multicentre, prospective study.
    Hansen MB; Rasmussen LS; Svensson M; Chakrakodi B; Bruun T; Madsen MB; Perner A; Garred P; Hyldegaard O; Norrby-Teglund A;
    Sci Rep; 2017 Feb; 7():42179. PubMed ID: 28176831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Plasma Nitrite, L-Arginine and Asymmetric Dimethylarginine With Morbidity and Mortality in Patients With Necrotizing Soft Tissue Infections.
    Hansen MB; Rasmussen LS; Garred P; Pilely K; Wahl AM; Perner A; Madsen MB; Hedegaard ER; Simonsen U; Hyldegaard O
    Shock; 2018 Jun; 49(6):667-674. PubMed ID: 28863028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort study.
    Polzik P; Grøndal O; Tavenier J; Madsen MB; Andersen O; Hedetoft M; Hyldegaard O
    Sci Rep; 2019 Mar; 9(1):5098. PubMed ID: 30911053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocompromised status in patients with necrotizing soft-tissue infection.
    Keung EZ; Liu X; Nuzhad A; Adams C; Ashley SW; Askari R
    JAMA Surg; 2013 May; 148(5):419-26. PubMed ID: 23677405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of necrotising soft tissue infections: aspects of the innate immune response and effects of hyperbaric oxygenation-the protocol of the prospective cohort BIONEC study.
    Hansen MB; Simonsen U; Garred P; Hyldegaard O
    BMJ Open; 2015 May; 5(5):e006995. PubMed ID: 25967993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interactions between MASP-2, C4, and C2 and their activation fragments leading to complement activation via the lectin pathway.
    Wallis R; Dodds AW; Mitchell DA; Sim RB; Reid KB; Schwaeble WJ
    J Biol Chem; 2007 Mar; 282(11):7844-51. PubMed ID: 17204478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact and Progression of Organ Dysfunction in Patients with Necrotizing Soft Tissue Infections: A Multicenter Study.
    Bulger EM; May A; Bernard A; Cohn S; Evans DC; Henry S; Quick J; Kobayashi L; Foster K; Duane TM; Sawyer RG; Kellum JA; Maung A; Maislin G; Smith DD; Segalovich I; Dankner W; Shirvan A
    Surg Infect (Larchmt); 2015 Dec; 16(6):694-701. PubMed ID: 26381131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient's characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort study.
    Madsen MB; Skrede S; Perner A; Arnell P; Nekludov M; Bruun T; Karlsson Y; Hansen MB; Polzik P; Hedetoft M; Rosén A; Saccenti E; Bergey F; Martins Dos Santos VAP; ; Norrby-Teglund A; Hyldegaard O
    Intensive Care Med; 2019 Sep; 45(9):1241-1251. PubMed ID: 31440795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Lectin Complement Pathway in Patients with Necrotizing Soft Tissue Infection.
    Hansen MB; Rasmussen LS; Pilely K; Hellemann D; Hein E; Madsen MB; Hyldegaard O; Garred P
    J Innate Immun; 2016; 8(5):507-16. PubMed ID: 27355483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation in patients with systemic lupus erythematosus without nephritis.
    Mollnes TE; Haga HJ; Brun JG; Nielsen EW; Sjöholm A; Sturfeldt G; Mårtensson U; Bergh K; Rekvig OP
    Rheumatology (Oxford); 1999 Oct; 38(10):933-40. PubMed ID: 10534542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a necrotizing soft-tissue infection mortality risk calculator using NSQIP.
    Faraklas I; Stoddard GJ; Neumayer LA; Cochran A
    J Am Coll Surg; 2013 Jul; 217(1):153-160.e3; discussion 160-1. PubMed ID: 23628224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrotizing soft tissue infections: improved outcomes with modern care.
    Tillou A; St Hill CR; Brown C; Velmahos G
    Am Surg; 2004 Oct; 70(10):841-4. PubMed ID: 15534961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate and quick predictor of necrotizing soft tissue infection: Usefulness of the LRINEC score and NSTI assessment score.
    Harasawa T; Kawai-Kowase K; Tamura J; Nakamura M
    J Infect Chemother; 2020 Apr; 26(4):331-334. PubMed ID: 31711831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.